Class 4 Caution in use- Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets

Viatris UK Healthcare Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in the specified batches of Oxcarbazepine 150 mg, 300 mg & 600 mg Film-Coated Tablets do not contain the most up to date safety information.

MHRA Drug alert date: 17th June 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-viatris-uk-healthcare-ltd-oxcarbazepine-mylan-150-mg-300mg-600mg-film-coated-tablets-el-24-a-slash-22

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please contact:

Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com. Customer Services can be reached at +44 (0)1707 853 000 (select option 2).

Field Safety notice-Tegaderm - Transparent Film Dressing Frame Style

We have received a recall notice from 3M regarding two batches of Tegaderm Transparent film dressings

Date of recall: 31/05/24

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Paracetamol 500mg, 1000mg Film-Coated Tablets Drugs R Us

Dawa Limited has informed the MHRA that specified batches listed in this notification have been packed with an outdated Patient Information Leaflet (PIL).

MHRA Drug alert date: 10th June 2024

MHRA drug alert link  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-dawa-limited-paracetamol-500mg-1000mg-film-coated-tablets-el-24-a-slash-21

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical information and stock control queries please contact Drugsrus Limited (distributor) on 020 8423 3800 or email info@drugsrus.co.uk.

Class 3 recall-Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules

Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-neuraxpharm-uk-ltd-atomoxetine-10mg-18mg-25mg-40mg-capsules-el-24-a-slash-19

Further Information

For medical information enquiries please contact medinfo-uk@neuraxpharm.com or telephone +44 (0) 118 211 4039

For stock control enquiries please contact info-uk@neuraxpharm.com  or telephone +44 (0) 118 211 4039

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Class 2 recall-Lamotrigine Desitin oral suspension

Desitin Pharma UK Ltd is recalling all batches of Lamotrigine Desitin 10mg/ml Oral Suspension as a precautionary measure due to an out of specification observation in the appearance of samples during routine stability testing. Please note this is a Class 2 Patient, Pharmacy and Wholesaler level recall.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-desitin-pharma-uk-ltd-lamotrigine-desitin-10mg-slash-ml-oral-suspension-el-24-a-slash-20?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9f3210f7-f22d-4437-be34-72c69edae87e&utm_content=immediately

Further Information

For medical information enquiries please contact medinfo@desitin.co.uk. For stock control enquiries please contact alison.wilton@desitin.co.uk.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Betamethasone Ointment 0.1% 30g

Manx Healthcare Ltd. has informed MHRA that they have identified a problem with the product packaging of the batch indicated

MHRA Drug alert date: 3rd June 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-manx-healthcare-ltd-dot-betamethasone-valerate-0-dot-1-percent-ointment-el-24-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f6354607-981b-4e64-96f4-50ae75da2efb&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medinfo@manxhealthcare.com, or telephone: +44 (0)1926 482511.

For stock control enquiries please contact customerservice@manxhealthcare.com, or telephone: +44 (0)1926 482511.

Class 4 caution in use-Freeflex Sodium chloride 0.9%

Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.

MHRA drug alert date: 22nd May 2024

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-fresenius-kabi-limited-sodium-chloride-0-dot-percent-intravenous-infusion-bp-freeflex-and-freeflex-plus-el-24-a-slash-17

This is a caution in use only we are not accepting stock returns

Further Information

For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0) 1928 533575.

For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758.

UPDATE: Class 3 recall-PI Keppra tablets 500mg

The class 4 caution in use on the below has now progressed to a Class 3 recall

Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V.

MHRA drug alert date: 15th May 2024

MHRA Drug alert link:  https://www.gov.uk/drug-device-alerts/class-3-medicines-defect-information-doncaster-pharma-limited-keppra-500mg-film-coated-tablets-el-24-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f0fe931b-3d3e-4a6b-b1e7-e0cfec019c27&utm_content=immediately

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Further Information

For medical information and stock control enquiries please contact Doncaster Pharma on tel. 01302 365 000, email quality.enquiries@doncasterpharma.co.uk or commercial@doncasterpharma.co.uk

Class 4 Caution in use-Trazodone 50mg/ml oral solution

Cygnus Pharma Ltd. Have informed MHRA that the European Article Number (EAN) barcode printed on various packs of Trazodone Hydrochloride 50mg/5ml Oral Solution, is defective and returns the incorrect information

MHRA drug alert date: 22nd May 2024

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cygnus-pharma-ltd-trazodone-hydrochloride-50mg-slash-5ml-oral-solution-el-24-a-slash-16

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.

For stock control enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.

Class 4 caution in use-PI Keppra tablets 500mg

Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V.

MHRA drug alert date: 15th May 2024

MHRA Drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-doncaster-pharma-limited-keppra-500mg-film-coated-tablets-el-24-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=db11fb3d-2987-42ea-8b51-47915e1572c3&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control enquiries please contact Doncaster Pharma on tel. 01302 365 000, email quality.enquiries@doncasterpharma.co.uk or commercial@doncasterpharma.co.uk